Brain Tumors in Adults

We take on the most difficult to treat brain tumors, including glioblastomas, gliomas, astrocytomas, meningiomas, and metastatic brain tumors. We’re nationally known for providing innovative precision molecular diagnoses for brain tumors, and for our expertise in neurosurgery, neuro-oncology, and Gamma Knife®, a precisely targeted radiation treatment for complex brain tumors. We believe that, in some cases, the standard of care may be outdated and might not be the best treatment for you. That’s why we base your care plan on the tumor’s precise molecular makeup, delivering truly individualized care with compassion. We also design cutting-edge clinical trials to find promising new treatments.

Clinical Trials and Research Studies

Phase 2

ANBL19P1: A Pilot Study of Dinutuximab Sargramostim (GM-CSF) and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma

Learn More

Phase 6

GBM Agile Trial

Learn More

Phase 3

A Pivotal Randomized Open-Label Study of Optune (TTFields 200khz) Concomitant with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

Learn More

Phase 2

An Open-label Single-arm Single-dose Prospective Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases after Radiation Therapy (PURSUE)

Learn More